- Home
- / CanniMed
CanniMed
Revenue
$16.7 M
FY, 2017
CanniMed Summary
Company Summary
- Overview
- CanniMed is a brand of pharmaceutical-grade cannabis provided by Aurora Cannabis. It offers a range of dried cannabis and oil cannabis products. The company delivers solutions that enable people to manage the symptoms of chronic disabilities and terminal illnesses.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2013
- HQ
- Saskatoon, CA | view all locations
- Website
- http://www.cannimed.ca
- Cybersecurity rating
Table of Contents
Operating MetricsView all
Medical Cannabis Sold, grams
582K
90.2%
FY, 2015
Revenue per Gram of Marijuana Equivalent
$9.8
11.9%
Q3, 2016
Total Dried Marijuana Equivalent Sold, grams
255K
71.1%
Q3, 2016
CanniMed Financials
Summary Financials
- Revenue (Q1, 2018)
- $C4.8M
- Gross profit (Q1, 2018)
- $C4.2M
- Net income (Q1, 2018)
- $C5.3M
- Cash (Q1, 2018)
- $C42.3M
- EBIT (Q1, 2018)
- $C8.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025